The cholesteryl ester transfer protein is suggested as a possible novel target for raising HDL-C and inhibiting atherosclerosis [29], although on the basis of the results obtained in large scale cardiovascular clinical outcome trials, the future of CETP inhibition as a potential therapeutic option for reducing major cardiovascular events is currently uncertain [45]. The gene discussed is CETP; the disease is atherosclerosis.